| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |